Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus

被引:87
作者
Torres, B
Aguilar, F
Franco, E
Sánchez, ES
Sánchez-Román, J
Alonso, JJ
Núñez-Roldán, A
Martín, J
González-Escribano, MF
机构
[1] Univ Seville, Serv Immunol, Hosp Virgen Rocio, Seville 41013, Spain
[2] CSIC, Granada, Spain
[3] Univ Granada, Hosp Virgen Nieves, Granada, Spain
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 07期
关键词
D O I
10.1002/art.20347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To investigate the possible association of the CT60A/G marker with systemic lupus erythematosus (SLE) in Spanish patients, and to identify the possible CTLA4 haplotype responsible for the association, taking into account other polymorphisms described at positions -1722T/C, -319C/T, +49A/G, and the microsatellite (AT)(n) in the 3'-untranslated region (3'-UTR) of the CTLA4 gene. Methods. Genotyping of CT60 was performed in 395 patients with SLE and 293 healthy controls using polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis. Genotyping of the rest of the dimorphisms has been previously reported. Genotyping of microsatellite polymorphism (AT),, in the 3'-UTR was performed using PCR with a fluorescence-labeled primer. Results. With regard to CT60A/G, the frequency of the AA genotype was significantly decreased among the SLE patients (18.7% versus 28.3% in the control group; P = 0.003, corrected P[P-corr] = 0.009, odds ratio [OR] = 0.58, 95% confidence interval [95% CI] 0.400.85). In other words, the frequency of individuals bearing the G phenotype was increased in the patient group compared with the control group (81.2% versus 71.7%; P = 0.003, P-corr = 0.006, OR = 1.71, 95% CI 1.18-2.49). The distribution of allele frequency was also significantly different between patients and controls (P = 0-01, P-corr = 0.02, OR [for allele G] = 1.32, 95% CI 1.06-1.65). After combining the data on the different polymorphisms, 2 neutral haplotypes were found: +49A;(AT)(7) ;CT60A and +49G;(AT)(8-19);CT60G. In addition, a susceptibility haplotype was found: +49A; (AT),;CT60G. Conclusion. The 3'-UTR of the CTLA4 gene is involved in susceptibility to SLE.
引用
收藏
页码:2211 / 2215
页数:5
相关论文
共 30 条
[1]   CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus [J].
Aguilar, F ;
Torres, B ;
Sánchez-Román, J ;
Núñez-Roldán, A ;
González-Escribano, MF .
HUMAN IMMUNOLOGY, 2003, 64 (10) :936-940
[2]   Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population [J].
Ahmed, S ;
Ihara, K ;
Kanemitsu, S ;
Nakashima, H ;
Otsuka, T ;
Tsuzaka, K ;
Takeuchi, T ;
Hara, T .
RHEUMATOLOGY, 2001, 40 (06) :662-667
[3]  
D'Alfonso S, 2000, ARTHRITIS RHEUM, V43, P120, DOI 10.1002/1529-0131(200001)43:1<120::AID-ANR15>3.0.CO
[4]  
2-3
[5]   An Mse I RFLP in the human CTLA4 promotor [J].
Deichmann, K ;
Heinzmann, A ;
Bruggenolte, E ;
Forster, J ;
Kuehr, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (03) :817-818
[6]   CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus [J].
Donner, H ;
Rau, H ;
Walfish, PG ;
Braun, J ;
Siegmund, T ;
Finke, R ;
Herwig, J ;
Usadel, KH ;
Badenhoop, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :143-146
[7]   A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families [J].
Gaffney, PM ;
Kearns, GM ;
Shark, KB ;
Ortmann, WA ;
Selby, SA ;
Malmgren, ML ;
Rohlf, KE ;
Ockenden, TC ;
Messner, RP ;
King, RA ;
Rich, SS ;
Behrens, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14875-14879
[8]   The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus [J].
Heward, J ;
Gordon, C ;
Allahabadia, A ;
Barnett, AH ;
Franklyn, JA ;
Gough, SCL .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (03) :193-195
[9]  
HORWITZ DA, 1997, DUBOIS LUPUS ERYTHEM, P155
[10]   CTLA-4 gene polymorphisms in systemic lupus erythematosus:: a highly significant association with a determinant in the promoter region [J].
Hudson, LL ;
Rocca, K ;
Song, YW ;
Pandey, JP .
HUMAN GENETICS, 2002, 111 (4-5) :452-455